Abstract 1744: Preclinical efficacy of a selective, orally bioavailable HER2 small molecule inhibitor targeting HER2 alterations and Enhertu-resistant cancers
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Jiyoung Jeon, Sun Young Jang, Ho Yeon Nam, HyungSeok Yoo, Jooyun Byun, Gunwoo Lee, Soye Jeon, Young Gil Ahn
Institution: Hanmi Pharmaceutical (South Korea)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409625307